Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Adage Capital Management, L.P. reported a 9.87% stake in Amylyx Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Adage Capital Management, L.P. reported a 9.87% stake in Amylyx Pharmaceuticals, Inc., 8,800,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 9.87%
- Shares
- 8,800,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 9.87% | 8,800,000 |
| Robert Atchinson | 9.87% | 8,800,000 |
| Phillip Gross | 9.87% | 8,800,000 |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Adage Capital Management, L.P.
- Amylyx Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Feb 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · May 12, 2025
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026